BCL2 and chronic kidney disease: Meanwhile, the JPYS formula counteracted CKD-mediated apoptosis evidenced by the increased protein abundance of Bax with a concomitant decline in Bcl-2 expression along with an increased Bax/Bcl-2 ratio (Figures 5C–F).